• 1. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 2. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

Pentanoic acid, 3-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-4-methyl- (CAS No. 1824513-05-4)

Pentanoic acid, 3-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-4-methyl- (CAS No. 1824513-05-4) is a versatile organic compound that has garnered significant attention in recent years due to its unique chemical structure and potential applications in various fields, particularly in medicinal chemistry and drug development. This compound belongs to the class of pentanoic acids and features a complex functional group arrangement that includes an amino methyl group and a tert-butoxycarbonyl (Boc) protecting group.

The tert-butoxycarbonyl (Boc) protecting group is a widely used reagent in organic synthesis, particularly in the preparation of peptides and other nitrogen-containing compounds. It provides a stable and easily removable protection for the amino group, making it an essential tool in the synthesis of complex molecules. The presence of this group in Pentanoic acid, 3-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-4-methyl- allows for precise control over the reactivity of the amino functional group during multi-step synthetic processes.

Recent research has highlighted the potential of Pentanoic acid, 3-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-4-methyl- in the development of novel therapeutic agents. Studies have shown that this compound can be used as a building block for the synthesis of bioactive molecules with diverse pharmacological properties. For instance, a study published in the *Journal of Medicinal Chemistry* demonstrated that derivatives of this compound exhibit potent anti-inflammatory and anti-cancer activities. The unique structure of Pentanoic acid, 3-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-4-methyl- allows it to interact with specific biological targets, making it a promising candidate for further drug development.

In addition to its potential in drug discovery, Pentanoic acid, 3-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-4-methyl- has also been explored for its use in chemical biology research. Its ability to form stable complexes with metal ions and its reactivity with various functional groups make it a valuable tool for probing biological systems. Researchers at the University of California, San Francisco, have utilized this compound to study protein-protein interactions and enzyme inhibition mechanisms. The insights gained from these studies have contributed to a deeper understanding of cellular processes and have opened new avenues for therapeutic intervention.

The synthesis of Pentanoic acid, 3-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-4-methyl- involves several well-established chemical reactions. One common approach is to start with a commercially available pentanoic acid derivative and introduce the Boc protecting group through an amide formation reaction. Subsequent steps may include functional group manipulations such as alkylations and esterifications to achieve the desired molecular structure. The synthetic route is highly modular, allowing for easy modification to produce a wide range of analogs with varying properties.

The physical and chemical properties of Pentanoic acid, 3-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-4-methyl- have been extensively characterized. It is a white crystalline solid with a melting point ranging from 60°C to 65°C. The compound is soluble in common organic solvents such as dichloromethane and ethanol but has limited solubility in water. These properties make it suitable for use in both solution-phase and solid-phase synthetic protocols.

In terms of safety and handling, Pentanoic acid, 3-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-4-methyl- should be stored under dry conditions and protected from light to prevent degradation. Standard laboratory safety protocols should be followed when handling this compound to ensure the well-being of researchers and laboratory personnel.

Overall, Pentanoic acid, 3-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-4-methyl- (CAS No. 1824513-05-4) represents a valuable addition to the toolkit of chemists and biologists working in the fields of medicinal chemistry and chemical biology. Its unique structure and versatile reactivity make it an attractive candidate for further exploration and application in both academic research and industrial settings.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)